Hinge Health files for an IPO, aiming for a NYSE listing under 'HNGE' as revenue jumps 33% to $390M in 2024 and net losses narrow significantly.

Welcome to Startups Weekly — your weekly recap of everything you can’t miss from the world of startups. Want it in your inbox ...

The updates aim to fortify the confidentiality, integrity and availability of electronic protected health information, or ePHI, amid escalating cybersecurity threats in healthcare. Once the proposed ...

Vori Health, a virtual musculoskeletal care company, closed a $53 million Series B funding round. Venture capital firm NEA ...

After scrapping plans for an IPO in 2022, Hinge Health Inc. is taking a more favorable view of going public given the increased support seen for health care and med-tech stocks in recent months. The ...

Most medical devices in the United States come to market with limited clinical data, and device surveillance is viewed as a ...

Hinge Health files IPO with CEO Daniel Perez holding 19% voting power. Major clients include HCSC, Elevance Health & Aetna.

Hinge Health, Inc. targets a $326B market with innovative musculoskeletal care solutions. Click here to find out more about the upcoming HNGE stock IPO.

In this week’s InnovationRx newsletter, the worsening measles outbreak, a noninvasive brain-computer implant, replacing heart ...

The digital health IPO market has slowed to a crawl in recent years, but it could be poised for a turnaround in 2025, experts ...

South Side-based biotech firm Carmell Corp. announced a comprehensive corporate rebrand and will now operate under the new ...

Venture capitalists backing Hinge Health, which sells software to help people dealing with chronic pain, were likely cheering ...